Följ
Yong Ai
Yong Ai
Verifierad e-postadress på rx.umaryland.edu
Titel
Citeras av
Citeras av
År
Synthesis of CDDO–amino acid–nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer
Y Ai, F Kang, Z Huang, X Xue, Y Lai, S Peng, J Tian, Y Zhang
Journal of Medicinal Chemistry 58 (5), 2452-2464, 2015
792015
Discovery of new monocarbonyl ligustrazine–curcumin hybrids for intervention of drug-sensitive and drug-resistant lung cancer
Y Ai, B Zhu, C Ren, F Kang, J Li, Z Huang, Y Lai, S Peng, K Ding, J Tian, ...
Journal of medicinal chemistry 59 (5), 1747-1760, 2016
762016
Gallium(III)–Salophen as a Dual Inhibitor of Pseudomonas aeruginosa Heme Sensing and Iron Acquisition
G Centola, DJ Deredge, K Hom, Y Ai, AT Dent, F Xue, A Wilks
ACS infectious diseases 6 (8), 2073-2085, 2020
482020
Identification of thiourea-based inhibitors of the B-cell lymphoma 6 BTB domain via NMR-based fragment screening and computer-aided drug design
H Cheng, BM Linhares, W Yu, MG Cardenas, Y Ai, W Jiang, A Winkler, ...
Journal of medicinal chemistry 61 (17), 7573-7588, 2018
452018
Serum Elabela/Toddler levels are associated with albuminuria in patients with type 2 diabetes
H Zhang, D Gong, L Ni, L Shi, W Xu, M Shi, J Chen, Y Ai, X Zhang
Cellular Physiology and Biochemistry 48 (3), 1347-1354, 2018
432018
Synthesis and in vitro antiproliferative evaluation of pyrimido [5, 4-c] quinoline-4-(3H)-one derivatives
Y Ai, YJ Liang, JC Liu, HW He, Y Chen, C Tang, GZ Yang, LW Fu
European journal of medicinal chemistry 47, 206-213, 2012
432012
Enhanced tumor selectivity of 5-fluorouracil using a reactive oxygen species-activated prodrug approach
Y Ai, ON Obianom, M Kuser, Y Li, Y Shu, F Xue
ACS medicinal chemistry letters 10 (1), 127-131, 2018
402018
Pyrazole-4-Carboxamide (YW2065): a therapeutic candidate for Colorectal Cancer via Dual activities of Wnt/β-Catenin signaling inhibition and AMP-Activated protein kinase (AMPK …
W Yang, Y Li, Y Ai, ON Obianom, D Guo, H Yang, S Sakamuru, M Xia, ...
Journal of medicinal chemistry 62 (24), 11151-11164, 2019
372019
Synthesis and biological evaluation of novel olean-28, 13β-lactams as potential antiprostate cancer agents
Y Ai, Y Hu, F Kang, Y Lai, Y Jia, Z Huang, S Peng, H Ji, J Tian, Y Zhang
Journal of Medicinal Chemistry 58 (11), 4506-4520, 2015
352015
Olean-28, 13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways
B Zhu, C Ren, K Du, H Zhu, Y Ai, F Kang, Y Luo, W Liu, L Wang, Y Xu, ...
Biochemical Pharmacology 170, 113642, 2019
322019
Nitrogen mustards as anticancer chemotherapies: historic perspective, current developments and future trends
B Diethelm-Varela, Y Ai, D Liang, F Xue
Current Topics in Medicinal Chemistry 19 (9), 691-712, 2019
322019
Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and Docking
Y Ai, ST Wang, PH Sun, FJ Song
International Journal of Molecular Sciences 11 (10), 3705-3724, 2010
312010
Tetramethylpyrazine blocks TFAM degradation and up-regulates mitochondrial DNA copy number by interacting with TFAM
L Lan, M Guo, Y Ai, F Chen, Y Zhang, L Xia, D Huang, L Niu, Y Zheng, ...
Bioscience reports 37 (3), BSR20170319, 2017
302017
Progress toward B-cell lymphoma 6 BTB domain inhibitors for the treatment of diffuse large B-cell lymphoma and beyond
Y Ai, L Hwang, AD MacKerell Jr, A Melnick, F Xue
Journal of medicinal chemistry 64 (8), 4333-4358, 2021
252021
Design and synthesis of new hybrids from 2-cyano-3, 12-dioxooleana-9-dien-28-oic acid and O 2-(2, 4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer
F Kang, Y Ai, Y Zhang, Z Huang
European Journal of Medicinal Chemistry 149, 269-280., 2018
232018
Triazole-based inhibitors of the Wnt/β-Catenin signaling pathway improve glucose and lipid metabolisms in diet-induced obese mice
ON Obianom, Y Ai, Y Li, W Yang, D Guo, H Yang, S Sakamuru, M Xia, ...
Journal of medicinal chemistry 62 (2), 727-741, 2019
212019
Molecular Modeling Studies on 11H-Dibenz[b,e]azepine and Dibenz[b,f][1,4]oxazepine Derivatives as Potent Agonists of the Human TRPA1 Receptor
Y Ai, FJ Song, ST Wang, Q Sun, PH Sun
Molecules 15 (12), 9364-9379, 2010
212010
Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer
S Lu, ON Obianom, Y Ai
Bioorganic & medicinal chemistry letters 28 (17), 2869-2874, 2018
202018
3D-QSAR and docking studies on pyridopyrazinones as BRAF inhibitors
Y Ai, ST Wang, C Tang, PH Sun, FJ Song
Medicinal Chemistry Research 20, 1298-1317, 2011
202011
Combined 3D-QSAR modeling and molecular docking studies on Pyrrole-Indolin-2-ones as Aurora A Kinase inhibitors
Y Ai, ST Wang, PH Sun, FJ Song
International Journal of Molecular Sciences 12 (3), 1605-1624, 2011
202011
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20